Nothing Special   »   [go: up one dir, main page]

Toppin et al., 2010 - Google Patents

A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene

Toppin et al., 2010

View PDF
Document ID
6461980655921543942
Author
Toppin P
Chandy T
Ghanekar A
Kraeva N
Beattie W
Riazi S
Publication year
Publication venue
Canadian Journal of Anesthesia/Journal canadien d'anesthésie

External Links

Snippet

Résumé Objectif Signaler l'identification d'une nouvelle mutation du gene CACNA1S, qui code la sous-unite alpha 1 (Cav1. 1) du canal calcique voltage-dependant de type L des cellules musculaires squelettiques chez une patiente souffrant d'hyperthermie maligne …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Toppin et al. A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene
Zhang et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk
Sia et al. Influence of mu-opioid receptor variant on morphine use and self-rated pain following abdominal hysterectomy
CN102483415B (en) Based on the genotypic cancerous diagnose of ODC1 and treatment
Chang et al. Gene polymorphisms of interleukin-10 and tumor necrosis factor-α are associated with contrast-induced nephropathy
Vanhille et al. A novel ERAP 2 haplotype structure in a C hilean population: implications for ERAP 2 protein expression and preeclampsia risk
US20230287502A1 (en) Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Variants And Uses Thereof
Bao et al. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals
Takahashi et al. Association of a polymorphism at the 5′‐region of the angiotensin II type 1 receptor with hypertension
Zhu et al. CTLA4 gene polymorphisms are associated with chronic bronchitis
JP2010142252A (en) Protein c polymorphism useful as indicator of patient outcome
Lesage et al. Genetic studies of the renin-angiotensin system in arterial hypertension associated with non-insulin-dependent diabetes mellitus
US10258606B2 (en) Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy
Buraczynska et al. Tumor necrosis factor-α gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease
Kim et al. The effects of β2 adrenoceptor gene polymorphisms on pressor response during laryngoscopy and tracheal intubation
Chang et al. TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance
Toppin et al. Un cas d’hyperthermie maligne fulminante chez une patiente présentant une nouvelle mutation du gène CACNA1S
WO2021061697A1 (en) Predicting neonatal complications using genetic variation
Ding et al. A family with Liddle's syndrome caused by a new c. 1721 deletion mutation in the epithelial sodium channel β‑subunit
Wang et al. Two novel deleterious variants of Angiotensin‐I‐converting Enzyme gene identified in a family with recurrent anhydramnios
JP2006520199A (en) Plasminogen activator inhibitor-1 (PAI-1) haplotype useful as an indicator of patient outcome
US20160010155A1 (en) KCNK3 Channel Loss-of-Function Mutants in Familial and Idiopathic Pulmonary Arterial Hypertension
KR20060096437A (en) Genetic markers for obesity
Patel et al. Angiotensin II type I receptor gene polymorphism in essential hypertensive and normotensive subjects
WO2020223657A1 (en) Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk